EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Byrsonima crassifolia : Ethnobotany, Phytochemistry, and Pharmacology – An Update

João de Jesus Oliveira Junior iD, Débora Luana Ribeiro Pessoa iD, Marilene Oliveira da Rocha Borges iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71756 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von João de Jesus Oliveira Junior und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biotechnology, Northeast Biotechnology Network (RENORBIO), Federal University of Maranhão, São Luís, Maranhão, Brazil. Hauptthemen laut MEDLINE: Phytochemicals. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Byrsonima crassifolia is a fruit‐bearing species widely distributed across tropical regions of the Americas with potential health applications. This review updates the knowledge base on its traditional uses, phytochemicals, and pharmacological activities to support future research.​ Native communities employ it as a key food and artisanal resource. As a medicinal plant, it has a history of treating diarrhea, diabetes, inflammation, and other conditions.​ Extracts and fractions, mainly from leaves and fruits, reveal numerous bioactive compounds, particularly non‐flavonoid polyphenols, flavonoids, and terpenoids. In vivo and in vitro evidence shows convergence between traditional medicine and a range of pharmacological activities, including antimicrobial, anti‐inflammatory, hypoglycemic, and gastroprotective effects; other reports indicate antioxidant, neuromodulatory, photoprotective, chemopreventive, and antitumor properties.​ Various studies link these pharmacological findings to the antioxidant profile of polyphenols identified in the species. Additionally, individual terpenoids isolated from seeds show promising effects on infection, inflammation, and glycemic control.​ Collectively, these findings indicate that the use of B. crassifolia and its bioactive compounds has a scientific basis. However, future research must advance in extract standardization, chemical marker quantification, molecular mechanism exploration, toxicity testing, and clinical trials to validate its therapeutic potential.​

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytochemicalsHumansAnimalsEthnobotanyAntioxidantsHypoglycemic AgentsPlant ExtractsAnti-Infective AgentsAnti-Inflammatory Agents

Stichwörter der Autor:innen

Byrsonima crassifoliaantidiabetic activityantioxidant activityanti‐inflammatory activityphytochemistrytraditional medicine

Substanzen

PhytochemicalsAntioxidantsHypoglycemic AgentsPlant ExtractsAnti-Infective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Graduate Program in Biotechnology, Northeast Biotechnology Network (RENORBIO), Federal University of Maranhão, São Luís, Maranhão, Brazil.
  • Special Coordination of Physiological Sciences and Pathology, Center for Biological and Health Sciences, Federal University of Maranhão, São Luís, Maranhão, Brazil.

ORCID-Profile: João de Jesus Oliveira Junior, Débora Luana Ribeiro Pessoa, Marilene Oliveira da Rocha Borges

Zitieren

APA

Oliveira Junior, J. J., Pessoa, D. L. R., & Borges, M. O. D. R. (2026). Byrsonima crassifolia : Ethnobotany, Phytochemistry, and Pharmacology – An Update. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71756

Vancouver

Oliveira Junior JJ, Pessoa DLR, Borges MODR. Byrsonima crassifolia : Ethnobotany, Phytochemistry, and Pharmacology – An Update. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71756

BibTeX
@article{OliveiraJunior2026,
  author = {Oliveira Junior, João de Jesus and Pessoa, Débora Luana Ribeiro and Borges, Marilene Oliveira da Rocha},
  title = {Byrsonima crassifolia : Ethnobotany, Phytochemistry, and Pharmacology – An Update},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71756}
}
Kostenlos starten →